Pharmacist-Led telehealth aims to tame gout flares in veterans

NCT ID NCT06887452

First seen Feb 28, 2026 · Last updated Jun 23, 2026 · Updated 19 times

Summary

This study compares two ways of managing gout medications in 310 veterans. One group gets standard care, while the other has regular telehealth check-ins with a pharmacist to adjust uric acid-lowering drugs. The goal is to see if pharmacist support helps more people reach healthy uric acid levels and have fewer gout attacks over two years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GOUT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA

    Philadelphia, Pennsylvania, 19104-4551, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE

    Omaha, Nebraska, 68105-1850, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • VA Portland Health Care System, Portland, OR

    Portland, Oregon, 97207-2964, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA

    Seattle, Washington, 98108-1532, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • VA Salt Lake City Health Care System, Salt Lake City, UT

    Salt Lake City, Utah, 84148-0001, United States

    Contact Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

allopurinol or febuxostat

What this could lead to

If successful, this could show that pharmacist-led telehealth helps more people with gout reach their uric acid goals and have fewer painful flares.

What could go wrong

This is a relatively small, early-stage study focused on care delivery, not a new drug. Results may not apply outside the VA system, and individual responses to medication can vary.

Conditions

The condition(s) this trial relates to.

Arthritis, Gouty gout

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.